More importantly, we set up a link between UHMK1 and IL6/STAT3 signaling, proposing UHMK1 could augment this signaling pathway by a positive feedback loop to promote CRC development and chemoresistance. This evidence concerns the gene IL6 and colorectal carcinoma.